Search Results for "Amplatzer Device Wiki"
Original Source: Erosion of an amplatzer septal occluder device into the aortic root.
Atrial septal defects can be closed surgically or percutaneously. We report a patient who underwent percutaneous closure of an atrial septal defect with an Amplatzer septal occluder device (AGA Medical Corp, Golden Valley, MN). The patient presented 4 months later with congestive heart failure secondary to an erosion of the Amplatzer septal occluder into the aortic root. The device was removed surgically, and the fistula was repaired. Amplatzer septal occluder indications, selection criteria, and complicati...
Matching Channels
Devices - medical, biotech, pharma
A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery. Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...
The Top 10 Medical Device Companies
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...
The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...
Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...
Becton Dickinson is one of the top 10 medical device companies in the world. It reported annual sales of just over $7 billion in 2010, and quarterly trends have seen encouraging increases. Some of...
Matching News
St Jude presents Amplatzer PFO Occluder device additional study data
St Jude Medical has presented additional data from RESPECT trial of its double-disc Amplatzer PFO Occluder device.
St. Jude presents positive results from Amplatzer PFO occluder device study
St. Jude Medical, a US-based provider of medical technologies, has presented positive results from RESPECT clinical study of its Amplatzer PFO occluder device.
St. Jude Medical’s AMPLATZER Amulet device receives European CE Mark approval
St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its AMPLATZER Amulet Left Atrial Appendage Occluder.
St. Jude's Amplatzer Can't Cure A Broken Heart
By EP Vantage:St. Jude Medical is unlikely to be able to secure U.S. approval for its Amplatzer device, a tiny mesh plug used to close holes in the heart, after it failed in two late-stage trials....
St. Jude reports first implant in ACP device trial
St. Jude Medical has implanted the first patient in a clinical study of its Amplatzer Cardiac Plug (ACP) device, designed for the prevention of stroke in patients with non-valvular atrial fibrillation...
FDA clears St Jude Medical Amplatzer Vascular Plug 4
The US Food and Drug Administration (FDA) has approved St Jude Medical's Amplatzer Vascular Plug 4.
St Jude Medical gains CE Mark for new cardiac device for stroke prevention
Medical device manufacturer St. Jude Medical announced that it has gained European CE Mark approval for its AMPLATZER Amulet Left Atrial Appendage Occluder, a new cardiac device that can prevent heart...
TCT: Plugging PFOs No Help for Stroke -- Maybe (CME/CE)
MIAMI (MedPage Today) -- Two randomized trials evaluating the ability of the Amplatzer Occluder device to reduce recurrent stroke in patients with a patent foramen ovale (PFO) failed to meet their pri...
Matching PubMed Articles
Erosion of an amplatzer septal occluder device into the aortic root.
Atrial septal defects can be closed surgically or percutaneously. We report a patient who underwent percutaneous closure of an atrial septal defect with an Amplatzer septal occluder device (AGA Medica...
The new Amplatzer duct occluder II: when is its use advantageous?
OBJECTIVES: To determine the safety and efficacy of the Amplatzer duct occluder and the Amplatzer duct occluder II in different types of arterial ducts, and to determine in which types of ducts the us...
Transcatheter occlusion of the left atrial appendage-Experimental testing of a new amplatzer device.
Objectives: This study assessed the feasibility and efficacy of implanting a new nitinol device in the left atrial appendage (LAA) in a canine model. Background: Left atrial thrombus occurs in the LAA...
Occlusion of Fontan fenestrations using Amplatzer septal occluder.
The objective of the study is to assess efficacy and safety of the Amplatzer septal device for percutaneous occlusion of Fontan fenestration. Fenestration improves postoperative outcomes in children u...
Percutaneous left atrial appendage (LAA) closure might reduce the cardioembolic risk in those patients with nonvalvular atrial fibrillation who are not candidates for warfarin therapy. This report pre...
